Ani Pharmaceuticals (ANIP) EV to EBIT (2013 - 2026)
Ani Pharmaceuticals' (ANIP) EV to EBIT came in at 10.74 for Q2 2026, down 86.8% from 81.55 a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EV to EBIT (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to EBIT at Ani Pharmaceuticals was 5.02, down 90.5% year-over-year; for FY2025, it came in at 13.41, down 99.2% from FY2024.
- In prior years, Ani Pharmaceuticals' EV to EBIT was 1749.94 in FY2024 and 19.63 in FY2023.
- The Q2 2026 figure stands as the lowest quarterly EV to EBIT since Q1 2016.
- On a year-over-year basis, EV to EBIT has declined in each of the last four quarters, with growth averaging 152.6% over the last seven quarters.
- The strongest year-over-year quarter for EV to EBIT in the past five years was Q1 2025, with growth of 852.4%; the weakest was Q4 2025, with a decline of 99.2%.
- According to Business Quant data, EV to EBIT for the three prior quarters was 12.25 (Q1 2026), 13.41 (Q4 2025) and 25.73 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.74 |
| Mar 31, 2026 | 12.25 |
| Dec 31, 2025 | 13.41 |
| Sep 30, 2025 | 25.73 |
| Jun 30, 2025 | 81.55 |
| Mar 31, 2025 | 207.26 |
| Dec 31, 2024 | 1,749.94 |
| Sep 30, 2024 | 97.31 |
| Jun 30, 2024 | 22.48 |
| Mar 31, 2024 | 21.76 |
| Dec 31, 2023 | 19.63 |
| Sep 30, 2023 | 23.92 |
| Jun 30, 2023 | 48.69 |
| Mar 31, 2020 | 114.90 |
| Dec 31, 2019 | 41.79 |
| Sep 30, 2019 | 25.27 |
| Jun 30, 2019 | 27.03 |
| Mar 31, 2019 | 24.37 |
| Dec 31, 2018 | 13.87 |
| Sep 30, 2018 | 19.99 |
API Access
Ani Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();